Osteoprotegerin serum levels in women: correlation with age, bone mass, bone turnover and fracture status.
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Pre-clinical data have shown that osteoprotegerin (OPG) inhibits osteoclast function and therefore plays an important role in bone remodelling. This study aimed to evaluate the clinical value of serum OPG. Do higher OPG serum levels reflect decreased bone resorption and perhaps higher bone mass in women? Serum OPG levels were measured in 177 healthy women (aged 17-85 years) and in 48 untreated patients (mean age 71 +/- 5) with established osteoporosis, and related to age, bone mass, markers of bone turnover and, in the case of patients with osteoporosis, to pre-existing vertebral fractures. In healthy women OPG levels showed a positive correlation with age (r = 0.25, p < 0.001) but not to bone mass or markers of bone turnover. In women with osteoporosis, however, there was a strong relationship between serum OPG and markers of bone turnover (serum c-terminal crosslinked telopeptides of thpe I collagen (sCTX): r = +0.82, p < 0.0001; osteocalcin (OC): r = +0.69, p < 0.0001), with patients who had higher levels of bone-turnover markers showing higher serum levels of OPG. After adjustment for bone mass and bone markers, patients with pre-existing vertebral fractures had significantly lower serum OPG levels than patients without fractures (57 +/- 8 vs. 97 +/- 10 pg/ml, [mean +/- SE], p < 0.01). The age-dependent increase of OPG as an antiresorptive factor may reflect an insufficient paracrine mechanism of bone cells to compensate for bone loss in older age. In patients with osteoporosis, however, OPG correlated strongly with markers of bone turnover; this may point toward a higher level of RANKL/OPG expression in these patients. Finally, low OPG serum levels seem to be associated with vertebral fractures. We hypothesise that low OPG levels in preset conditions of bone turnover may indicate a higher risk of fracture in patients with osteoporosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the evidence is conflicting about an association between markers of bone turnover and circulating OPG because some studies report an association (154,372,375) or an association only among osteoporotic women (384), and others report no association (373,379).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [384]
Citations
Cites
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,228
Professor Kanis, J. A., Melton, L. J., Christiansen, C., Johnston, C. C., & Khaltaev, N. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090802 · Cited by 3,849
Vertebral fracture assessment using a semiquantitative technique
Genant, H. K., Wu, C. Y., van Kuijk, C., & Nevitt, M. C. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080915 · Cited by 3,691
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351 · cited 1×
“As OPG is expressed not only by osteoblasts but also in high concentrations by a variety of tissues [1, 2, 7, 8, 25] and is a key regulator of the immune system [1, 2, 26, 27], interpretation of OPG serum levels in a cohort of patients, some of whom are in poor health, may be difficult.”
BackgroundOsteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.
Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., et al. (1998) · Genes & Development · doi:10.1101/gad.12.9.1260 · Cited by 2,483
Yasuda, H., Shima, N., Nakagawa, N., Mochizuki, S.-I., Yano, K., Fujise, N., Sato, Y., Goto, M., Yamaguchi, K., Kuriyama, M., et al. (1998) · Endocrinology · doi:10.1210/endo.139.3.5837 · Cited by 1,201
Hofbauer, L. C., Khosla, S., Dunstan, C. R., Lacey, D. L., Boyle, W. J., & Riggs, B. L. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.1.2 · Cited by 1,173
Hofbauer, L. C., Gori, F., Riggs, B. L., Lacey, D. L., Dunstan, C. R., Spelsberg, T. C., & Khosla, S. (1999) · Endocrinology · doi:10.1210/endo.140.10.7034 · Cited by 794 · cited 1×
“The importance of OPG may therefore be revealed only in the presence of pathological conditions or medication influencing bone metabolism [23, 24, 30, 31].”
Background
Research works printed but not linked: 2
- Bu R, McKeon RM, Cao L, Blair HC (2001) Osteoprotegerin (OPG) binds TNF family proteins including TNFα and protects osteoblasts from TNFα-induced apoptosis: a complementary function in addition to effects of OPG on osteoclast differentiation via RANKL. J Bone Miner Res 16 [Suppl 1]: S169 (Abstract)
- Holt MI, Baattrup A, Eriksen EF (2001) Expression of osteoclast differentiating factor (ODF, RANKL) and osteoprotegerin (OPG) in human bone: role of the bone remodeling compartment in the coupling between resorption and formation. J Bone Miner Res 16 [Suppl 1]: S364 (Abstract)
Cited by
Kearns, A. E., Khosla, S., & Kostenuik, P. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0014 · Cited by 824
Regulation of Vascular Calcification by Osteoclast Regulatory Factors RANKL and Osteoprotegerin
Collin-Osdoby, P. (2004) · Circulation Research · doi:10.1161/01.res.0000149165.99974.12 · Cited by 473
Dimorphic effects of Notch signaling in bone homeostasis
Engin, F., Yao, Z., Yang, T., Zhou, G., Bertin, T., Jiang, M. M., Chen, Y., Wang, L., Zheng, H., Sutton, R. E., et al. (2008) · Nature Medicine · doi:10.1038/nm1712 · Cited by 413
Rogers, A., & Eastell, R. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0794 · Cited by 215
Goëb, V., & Anne-Priscille, T. (2010) · Clinical Interventions in Aging · doi:10.2147/cia.s10153 · Cited by 179
Barreto, D. V., Barreto, F. D. C., Carvalho, A. B., Cuppari, L., Draibe, S. A., Dalboni, M. A., Moysés, R. M. A., Neves, K. R., Jorgetti, V., Miname, M. H., et al. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.06.024 · Cited by 144
The RANKL/OPG system and bone mineral density in patients with chronic liver disease
Moschen, A. R., Kaser, A., Stadlmann, S., Millonig, G., Kaser, S., Mühllechner, P., Habior, A., Graziadei, I. W., Vogel, W., & Tilg, H. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.05.034 · Cited by 129
Serum osteoprotegerin and its relationship with bone mineral density and markers of bone turnover.
Indridason, O. S., Franzson, L., & Sigurdsson, G. (2005) · Osteoporosis International · doi:10.1007/s00198-004-1699-x · Cited by 107
Dobnig, H., Hofbauer, L. C., Viereck, V., Obermayer-Pietsch, B., & Fahrleitner-Pammer, A. (2006) · Osteoporosis International · doi:10.1007/s00198-005-0035-4 · Cited by 76
Self-citationMartini, G., Gennari, L., Merlotti, D., Salvadori, S., Franci, M. B., Campagna, S., Avanzati, A., De Paola, V., Valleggi, F., & Nuti, R. (2007) · Bone · doi:10.1016/j.bone.2006.08.003 · Cited by 72
Attia, E. A. S., Khafagy, A. H., Abdel-Raheem, S. M., Ahmed, S. F., & Saad, A. A. (2010) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2010.04600.x · Cited by 74
Liu, J., Zhao, H., Ning, G., Zhao, Y. J., Chen, Y., Zhang, Z., Sun, L., Xu, M.-Y., & Chen, J. L. (2004) · Calcified Tissue International · doi:10.1007/s00223-004-0007-2 · Cited by 76
Wagner, D., & Fahrleitner‐Pammer, A. (2010) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-010-0818-x · Cited by 60
Self-citationDobnig, H., Piswanger-Sölkner, J. C., Obermayer-Pietsch, B. M., Tiran, A., Groselj‐Strele, A., Maier, E., Maritschnegg, P., Riedmüller, G., Brueck, C. C., & Fahrleitner‐Pammer, A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2079 · Cited by 53
Self-citationThe Circadian Rhythm of Osteoprotegerin and Its Association with Parathyroid Hormone Secretion
Joseph, F., Chan, B. Y., Durham, B. H., Ahmad, A. M., Vinjamuri, S., Gallagher, J. A., Vora, J. P., & Fraser, W. D. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1832 · Cited by 55
High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment
Amato, G., Mazziotti, G., Sorvillo, F., Piscopo, M., Lalli, E., Biondi, B., Iorio, S., Molinari, A. M., Giustina, A., & Carella, C. (2004) · Bone · doi:10.1016/j.bone.2004.04.021 · Cited by 57
Trofimov, S., Pantsulaia, I., Kobyliansky, E., & Livshits, G. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500305 · Cited by 51
Chi, G., Qiu, L., Ma, J., Wu, W., & Zhang, Y. (2023) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-023-04179-5 · Cited by 58
Traditional and Novel Bone Remodeling Markers in Premenopausal and Postmenopausal Women
Botella, S., Restituto, P., Monreal, I., Colina, I., Calleja, A., & Varo, N. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2264 · Cited by 41
RANKL inhibition for the management of patients with benign metabolic bone disorders
Anastasilakis, A. D., Toulis, K. A., Pοlyzos, S. A., & Terpos, E. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903048929 · Cited by 38
Uemura, H., Yasui, T., Miyatani, Y., Yamada, M., Hiyoshi, M., Arisawa, K., & Irahara, M. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03345584 · Cited by 41
Co-morbid manifestations in COPD
Wouters, E. F. �., Celis, M., Breyer, M., Rutten, E. P. A., Graat‐Verboom, L., & Spruit, M. A. (2007) · Respiratory Medicine COPD Update · doi:10.1016/j.rmedu.2007.08.003 · Cited by 33
Osteoimmunopathology in HIV/AIDS: A Translational Evidence-Based Perspective
Barkhordarian, A., Ajaj, R. A., Ramchandani, M. H., Demerjian, G. G., Cayabyab, R., Danaie, S., Ghodousi, N., Iyer, N., Mahanian, N., Phi, L., et al. (2011) · Pathology Research International · doi:10.4061/2011/359242 · Cited by 26
Doumouchtsis, K., Kostakis, A., Doumouchtsis, S. K., Tziamalis, M. P., Tsigris, C., Kostaki, M., & Perrea, D. N. (2007) · Journal of Endocrinological Investigation · doi:10.1007/bf03350814 · Cited by 25
Horst−Sikorska, W., Wawrzyniak, A., Celczyńska−Bajew, L., Marcinkowska, M., Dabrowski, S., Kalak, R., & Słomski, R. (2005) · PubMed · Cited by 24
Kim, C. S., Bae, E. H., Kwon, S., Han, S. H., Choi, K. H., Lee, J., Chae, D., Oh, K., Ahn, C., Kim, S. W., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166792 · Cited by 23
Effects of Parathyroid Hormone and Alendronate Alone or in Combination in Osteoporosis
Vegni, F. E., Corradini, C., & Privitera, G. (2004) · New England Journal of Medicine · doi:10.1056/nejm200401083500219 · Cited by 22
Angelopoulos, N., Goula, A., Katounda, E., Rombopoulos, G., Kaltzidou, V., Kaltsas, D., Malaktari, S., Athanasiou, V., & Tolis, G. (2006) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-006-0728-6 · Cited by 21
Tera, T. D. M., do Prado, R. F., Marco, A. C. D., Santamaria, M. P., & Jardini, M. A. N. (2014) · Brazilian Oral Research · doi:10.1590/1807-3107bor-2014.vol28.0054 · Cited by 20
Chiba, Y., Onouchi, T., Ikeda, T., Adachi, J., Tamura, Y., & Horiuchi, T. (2009) · Gerontology · doi:10.1159/000196280 · Cited by 23
Kraj, M. A., Owczarska, K., Sokołowska, U., Centkowski, P., Pogłód, R., & Kruk, B. (2005) · PubMed · Cited by 19
Amer, O. E., Wani, K., Ansari, M. G. A., Alnaami, A. M., Aljohani, N., Abdi, S., Hussain, S. D., Al‐Daghri, N. M., & Alokail, M. S. (2022) · Medicina · doi:10.3390/medicina58080976 · Cited by 19
Uemura, H., Yasui, T., Miyatani, Y., Yamada, M., Hiyoshi, M., Arisawa, K., & Irahara, M. (2007) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e318046369b · Cited by 17
Stuss, M., Sewerynek, E., Król, I., Stępień-Kłos, W., & Jędrzejczyk, S. (2016) · Endokrynologia Polska · doi:10.5603/ep.a2016.0014 · Cited by 18
Silva, H. C., Pinheiro, M. M., Genaro, P. D. S., Castro, C. H. D. M., Monteiro, C. M. C., Fonseca, F. A. H., & Szejnfeld, V. L. (2012) · Bone · doi:10.1016/j.bone.2012.11.004 · Cited by 16
Radzi, N. F. M., Ismail, N. A. S., & Alias, E. (2018) · Current Drug Targets · doi:10.2174/1389450119666180207092539 · Cited by 16
Reyes‐García, R., Muñoz‐Torres, M., García, D. F., Mezquita‐Raya, P., Salcedo, J. A. G., & Luna, J. D. D. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181ac0cc1 · Cited by 17
Osteoprotegerin and fractures in men and women with chronic kidney disease
West, S. L., Lok, C. E., & Jamal, S. A. (2013) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-013-0506-1 · Cited by 16
Vescovi, J. D., VanHeest, J. L., & Souza, M. J. D. (2007) · Contraception · doi:10.1016/j.contraception.2007.10.007 · Cited by 16
Ricci, P., Tauchmanovà, L., Risitano, A. M., Carella, C., Mazziotti, G., Lombardi, G., Colao, A., Rotoli, B., & Selleri, C. (2006) · Transplantation · doi:10.1097/01.tp.0000244588.42519.72 · Cited by 14
Piatek, S., Adolf, D., Wex, T., Halangk, W., Klose, S., Westphal, S., Amthauer, H., & Winckler, S. (2013) · Maturitas · doi:10.1016/j.maturitas.2013.01.005 · Cited by 12
Schulz, M. C., Kowald, J., Estenfelder, S., Jung, R., Kuhlisch, E., Eckelt, U., Mai, R., Hofbauer, L. C., Stroszczynski, C., & Stadlinger, B. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00426 · Cited by 10
Ling, Z., Wu, L., Shi, G., Chen, L., & Dong, Q. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4216 · Cited by 10
Gupta, V., Ekundayo, O., Németh, Z., Yang, Y., Covic, A. C., Máthé, Z., Kovesdy, C. P., Molnar, M. Z., & Mucsi, I. (2021) · Transplant International · doi:10.1111/tri.13847 · Cited by 9
Gunsser, J., Hermann, R., Roth, A. J., & Lupp, A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0227133 · Cited by 8
Age-related changes and reference intervals of RANKL, OPG, and bone turnover markers in Indian women
Nair, S. P., Hatkar, S., Patil, A. D., Surve, S. V., Joshi, B. N., Balasinor, N., & Desai, M. P. (2021) · Archives of Osteoporosis · doi:10.1007/s11657-021-01014-4 · Cited by 8
Serum markers of bone turnover in dialyzed patients separated according to age
Grzegorzewska, A. E., & Młot-Michalska, M. (2006) · International Urology and Nephrology · doi:10.1007/s11255-006-0079-1 · Cited by 8
Serum Osteoprotegerin and Sex Steroid Levels in Patients With Prostate Cancer
Varsavsky, M., Reyes‐García, R., Perez, M. D., Ramírez, A. R. G., Mijan, J. L., & Muñoz‐Torres, M. (2012) · Journal of Andrology · doi:10.2164/jandrol.111.014696 · Cited by 7
Chen, C., Liang, M.-K., Zhang, H., Peng, Y., Wu, X., Wu, X., & Liao, E.-Y. (2013) · Endocrine Research · doi:10.3109/07435800.2013.840654 · Cited by 6
Fojt, R., Pirk, J., Kamenický, P., Karpíšek, M., Straka, Z., Malý, M., & Motovska, Z. J. (2015) · Cardiovascular Pathology · doi:10.1016/j.carpath.2015.12.003 · Cited by 5
Renjithlal, S. L. M., Magdi, M., Mostafa, M. R., Renjith, K., Pillai, P., Syed, M., Mohamed, S., Zahid, V. F., Ritter, N., Ali, O. A., et al. (2022) · Journal of Endocrinology and Metabolism · doi:10.14740/jem840 · Cited by 4
Osteoimmunological Insight in to Vertebral Fractures in Osteoporosis
Saghafi, H., Hossein‐Nezhad, A., Sedighi, N., Tofighi, P., Soltani, A., Larijani, B. A., & Hafezi, R. (2008) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 4
Ramón‐Luing, L. A., Flores‐González, J., Cataneo‐Piña, D. J., Falfán‐Valencia, R., Pérez-Rubio, G., Buendía-Roldán, I., Selman, M., & Chávez‐Galán, L. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s545926 · Cited by 1
Liu, J., Zhao, H., Ning, G., Zhao, Y., Chen, Y., Zh, L., Sun, L., Xu, Y., & Chen, J. L. (2005) · Cited by 1
Emerging roles of osteocytes in the regulation of bone and skeletal muscle mass
Moin, M. R., Das, S., & Sanyal, S. (2024) · Journal of Molecular Endocrinology · doi:10.1530/jme-24-0033 · Cited by 1
Krampla, W. W., Newrkla, S., Huber, K., Hawa, G., Posch, M., Fendt, S., Katschnig, I., Kröner, A., Hayden, E., Kittl, E. M., et al. (2007) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Osteoporosis and Vascular Calcification: Lesson from OPG KO Mice
Kim, N. (2005) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2005.20.6.571
Mardock, M. A. (2003) · VTechWorks (Virginia Tech)
Okołodobowe stężenia DHEA a stan kośćca u otyłych kobiet po menopauzie
Ostrowska, Z., Kos‐Kudła, B., Marek, B., Kajdaniuk, D., Szapska, B., & Wołkowska-Pokrywa, K. (2011) · Via Medica Journals
Vitamin D Status, Estradiol and Bone Metabolism in Elderly Female Patients With Hip Fracture
Fakler, J., Dinger, J. G., Hammer, K.-H., Kratzsch, J., Roth, A. J., Kerner, C. J. C., & Aust, G. (2018) · International Journal of Orthopaedics · doi:10.17554/j.issn.2311-5106.2018.05.253
Chiappelli, F. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9495-0_2
Xu, W., Li, J., Zhou, J., & Zhang, G. (2025) · Research Square · doi:10.21203/rs.3.rs-7030982/v1
Metadata
- Authors
- Fahrleitner-Pammer, A., Dobnig, H., Piswanger-Soelkner, C., Bonelli, C., Dimai, H.-P., Leb, G., & Obermayer-Pietsch, B.
- Affiliations
- University of Graz (AT)
- Venue
- Wiener Klinische Wochenschrift
- Published
- 2003-05
- Volume
- 115
- Issue
- 9
- Pages
- 291-297
- ISSN
- 0043-5325 (ISSN-L)
- 1613-7671
- OpenAlex
- W86347301
- Cited by
- 62
- References
- 33
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 2 · 2019: 1 · 2018: 2 · 2017: 2 · 2016: 2 · 2015: 1 · 2014: 1 · 2013: 4 · 2012: 2
- FWCI
- 5.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Wiener klinische Wochenschrift (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Keywords
- osteoprotegerin, osteoporosis, vertebral fractures, bone turnover markers, bone mass, RANKL/OPG pathway, osteocalcin, C-terminal telopeptide of type I collagen, bone resorption, women, aging
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Aging, Bone Diseases, Metabolic, Bone Resorption, Female, Fractures, Spontaneous, Glycoproteins, Humans, Middle Aged, Reference Values, Bone Density, Osteoporosis, Postmenopausal, Spinal Fractures, Receptors, Tumor Necrosis Factor, Receptors, Cytoplasmic and Nuclear, Osteoprotegerin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.